Slangerup, Denmark

Anders Viksoe-Nielsen

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Bagsvaerd, DK (2020)
  • Slangerup, DK (2011 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anders Viksoe-Nielsen

Introduction

Anders Viksoe-Nielsen, hailing from Slangerup, Denmark, is a prominent inventor recognized for his significant contributions to the field of biotechnology. With a portfolio that includes 15 patents, Viksoe-Nielsen has been instrumental in advancing the science of enzyme variants, particularly in alpha-amylases, showcasing his innovative spirit and dedication to research.

Latest Patents

Among his latest inventions are patented variants of a parent alpha-amylase, which relates to polynucleotides encoding these variants. This groundbreaking invention also covers nucleic acid constructs, vectors, and host cells that utilize these polynucleotides, along with methods of employing the variant enzymes in various applications. These advancements highlight Viksoe-Nielsen’s commitment to enhancing enzyme performance and broadening their use in industrial processes.

Career Highlights

Throughout his career, Viksoe-Nielsen has made substantial contributions while working for renowned companies such as Novozymes A/S and Novo Zymes North America, Inc. His work in these organizations has played a crucial role in the development of innovative solutions for enzyme technology, leading to various applications in sectors such as agriculture, food, and bioenergy.

Collaborations

Anders Viksoe-Nielsen has collaborated with notable individuals like Carsten Schau Andersen and Peter Kamp Hansen, furthering innovation in enzyme technology. These professional relationships have fostered a vibrant environment of creativity and have led to significant scientific discoveries in the field.

Conclusion

In summary, Anders Viksoe-Nielsen stands out as a leading figure in the innovation of alpha-amylase variants. His extensive list of patents reflects not only his inventive capabilities but also his dedication to advancing the science of biotechnology. The impact of his work continues to resonate within the industry, promising further advancements in enzyme technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…